The great thirst for data in modern biomedical research is seldom followed by the formulation of models that can explain complex phenotypes by making thorough use of all the information collected. In NANOSOLUTIONS, all the data produced by the partners, including the characterisation of engineered nanomaterials (ENM) and the study of their effect on cell and animal models by a number of in vitro and in vivo experiments, will be systematically collected, organised and analysed in WP11.

The main goal of WP11 is the development of a computational model for predicting the safety of the nanomaterials, which we call the “ENM safety classifier”, by integrating all the data layers produced within the consortium.